Results 201 to 210 of about 27,075 (224)

Olaparib

Reactions Weekly, 2019
  +5 more sources

Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study)

Annals of Oncology, 2021
J -U Blohmer, S Seiler, P Kläre
exaly  

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Annals of Oncology, 2022
Matthew C Winter, Mariangela Ciccarese, Manuel Ruiz   +2 more
exaly  

Olaparib monotherapy as primary treatment in unselected triple negative breast cancer☆

Annals of Oncology, 2021
Jürgen Geisler, Violeta Serra, Per Eystein Lønning   +2 more
exaly  

Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial

Annals of Oncology, 2023
C Lefeuvre-Plesse, A Leary, G Bogner
exaly  

Two‐step flow synthesis of Olaparib in microreactor: Route design, process development and kinetics research

Chemical Engineering Journal, 2023
Yongjun Zang, Qi-Lin Xu
exaly  

Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38): a phase IIIb trial

Annals of Oncology, 2023
P Scollo, J Korach, R Madry
exaly  

Role of the efflux transporters Abcb1 and Abcg2 in the brain distribution of olaparib in mice

European Journal of Pharmaceutical Sciences, 2022
Jin Sook Song, Suk-Jae Chung, Min-Soo Kim   +2 more
exaly  

Pharmacokinetics, safety, and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial

Neuro-Oncology, 2020
Anthony J Chalmers, Catherine McBain, Karen Strathdee   +2 more
exaly  

Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety

Annals of Oncology, 2016
L R Molife, R L Coleman, U A Matulonis
exaly